Protia Inc. participated in the world’s largest medical device exhibition, MEDICA 2024, held in Düsseldorf, Germany, from November 11 to 14, where it introduced its diverse product lineup.

MEDICA is the world’s largest B2B medical device exhibition, has been held annually since 1969. This year’s event featured approximately 5,300 medical companies from 70 countries across an exhibition space of 140,000㎡. Around 330 companies from Korea also participated in the event.

During the exhibition, Protia showcased its products, including:

The Protia Allergy-Q 128M - a human allergy testing product capable of diagnosing 118 types of antigens,

The ANITIA Canine/Feline IgE - allergy testing kits for dogs and cats,

The PROTIA ANA Profile 18 - autoimmune diagnostic kit

The PROTIA AST DL001 - an antibiotic susceptibility diagnostic kit set (soon to be released).

A Protia representative stated, “We continuously participate in large-scale exhibitions like MEDICA to strengthen relationships with international clients and explore new business opportunities. Through this exhibition, we also aim to expand collaboration with global companies and further solidify our position in overseas markets.”